Physician profile
John Robinson, JR.
NPI 1063943025
$37,872.89
in general payments reported to CMS, 2019-2025
8 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,020 · 2023: $30K · 2024: $2,857 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $7,976 · Food and Beverage: $3,277 · Education: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $7,975.91 |
| Food and Beverage | $3,276.72 |
| Education | $2,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $24,009.95 | 2023-2025 | |
| Smith+Nephew, INC. | $5,411.06 | 2022-2023 | |
| Medical Device Business Services, INC. | $4,082.73 | 2023 | Dynacord, Inhance |
| Stryker Corporation | $2,061.69 | 2023-2025 | Mako, Gamma, Hoffmann |
| Pylant Medical | $1,209.20 | 2022 | |
| Core Surgical Group | $942.26 | 2023-2025 | |
| Evolution Surgical, INC | $102.87 | 2023 | |
| Depuy Synthes Sales INC. | $53.13 | 2023 | Fibulink, Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.